Apr 16, 2024 4:05pm EDT ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations
Mar 19, 2024 8:07am EDT ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC Deficiency
Mar 11, 2024 8:00am EDT Journal of Neurosurgery Publication Demonstrates Distinct Advantages of ClearPoint Prism® Neuro Laser Therapy System
Mar 01, 2024 4:05pm EST ClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024
Feb 29, 2024 8:00am EST ClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common Stock
Feb 21, 2024 4:05pm EST ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases Performed with the New 2.2 Software Version and the Integrated Maestro Brain Model
Jan 24, 2024 4:05pm EST ClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism® Neuro Laser Therapy System and Navigation System at Kaleida Health in Buffalo